As of 2024-12-12, the Fair Value of Apellis Pharmaceuticals Inc (APLS) is -10.05 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 34.00 USD, the upside of Apellis Pharmaceuticals Inc is -129.57%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -304.70 | -344.90 | -746.40 | -652.20 | -528.63 | -515.37 |
| YoY growth | -138.98% | -13.19% | -116.41% | 12.62% | 18.95% | -47.40% |
| Market Cap (mil) | 4,229.26 |
| P/E | |
| Forward P/E |
| EPS | -2.01 |
| Avg earnings growth rate | -47.40% |
| TTM earnings | -250.10 |